No retraction, correction or concern found when last checked on Oct 18, 2026.
Mapping the zoonotic niche of Ebola virus disease in Africa
David M Pigott, Nick Golding, Adrian Mylne and 16 more
eLife · 2014 · CC BY
Abstract
Ebola virus disease (EVD) is a complex zoonosis that is highly virulent in humans. The largest recorded outbreak of EVD is ongoing in West Africa, outside of its previously reported and predicted niche. We assembled location data on all recorded zoonotic transmission to humans and Ebola virus infection in bats and primates (1976–2014). Using species distribution models, these occurrence data were paired with environmental covariates to predict a zoonotic transmission niche covering 22 countries across Central and West Africa. Vegetation, elevation, temperature, evapotranspiration, and suspected reservoir bat distributions define this relationship. At-risk areas are inhabited by 22 million people; however, the rarity of human outbreaks emphasises the very low probability of transmission to humans. Increasing population sizes and international connectivity by air since the first detection of EVD in 1976 suggest that the dynamics of human-to-human secondary transmission in contemporary outbreaks will be very different to those of the past.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
Ebola viruses have for the last forty years been responsible for a number of outbreaks of Ebola virus disease (EVD) in humans, with high case fatality rates typically around 60–70%, but potentially reaching as high as 90%. The most recent outbreak began in Guinea in December 2013 and has subsequently spread to Liberia, Sierra Leone and Nigeria. The unprecedented size and scale of this ongoing outbreak has the potential to destabilise already fragile economies and healthcare systems, and fears of international spread of a Category A Priority Pathogen have made this a massive focus for international public health. This has led to the current outbreak being declared a Public Health Emergency of International Concern on the 8 August 2014.
The Filoviridae, of which Ebolavirus is a constituent genus, belong to the order Mononegavirales. Two other genera complete the family: Marburgvirus, itself responsible for a number of outbreaks of haemorrhagic fever across Africa and Cuevavirus, recently isolated from bats in northern Spain. Five species of Ebolavirus have been isolated to date; the earliest recognised outbreaks of EVD were reported in Zaire (now the Democratic Republic of the Congo [DRC]) and Sudan in 1976. The causative viruses were isolated and later identified to be distinct species, Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). A third species of Ebolavirus, Reston ebolavirus, was isolated from Cynomologus monkeys imported from the Philippines to a facility in the United States, where they experienced severe haemorrhaging. Whilst serological evidence of infection with this species has been reported in individuals in the Philippines, no pathogenicity has been reported beyond primates and porcids. In 1994 a fourth species, Tai Forest ebolavirus was isolated from a veterinarian who had autopsied a chimpanzee in Côte d’Ivoire, though the virus has not been detected subsequently. The final species, Bundibugyo ebolavirus, was responsible for an outbreak of EVD in Uganda in 2007, as well as a more recent outbreak in the DRC.
Initial analysis suggested that the viruses isolated from the current outbreak, originating in Guinea, formed a separate clade within the five Ebolavirus species. Subsequent re-analysis of the same sequences however, indicated that these isolates instead nest within the Zaire ebolavirus lineage, and diverged from Central Africa strains approximately ten years ago.
Which reservoir species are responsible for maintaining Ebola transmission between outbreaks is not well understood, but over the last decade significant progress has been made in narrowing down the list of likely hosts (Figure 1). Primates have long been known to harbour filoviral infections, with the first Marburg strains identified in African green monkeys in 1967. Significant mortality has also been reported in wild primate populations across Africa, most notably in gorilla (Gorilla gorilla) and chimpanzee (Pan troglodytes) populations. The high case fatality rates recorded in the great apes combined with their declining populations and limited geographical range, indicate they are likely dead-end hosts for the virus and not reservoir species. A large survey of small mammals in and around Gabon identified three species of bats which were infected with Ebola viruses—Hypsignathus monstrosus, Epomops franqueti and Myonycetris torquata. Subsequent serological surveys and evidence linking the potential source of human outbreaks to bats lend support to the hypothesis of a bat reservoir. This, coupled with repeated detection of Marburgvirus in the fruit bat Rousettus aegypticus and the only isolations of Cuevavirus also from bats (specifically Llovia virus), all support the suspicion that Chiroptera play an important role in the natural life-cycle of the filoviruses.
Humans represent a dead-end host for the virus, with only stuttering chains of transmission reported between humans in the majority of previous outbreaks and no indication that humans can reintroduce the virus back into reservoir species. The incubation period in humans ranges from two days to three weeks, after which a variety of clinical symptoms arise, affecting multiple organs of the body. At the peak of illness, haemorrhaging shock and widespread tissue damage can occur and can eventually lead to death within 6–16 days. Human-to-human transmission is mainly through direct unprotected contact with infected individuals and cadavers, with infectious particles detected in a number of different body fluids. The typical outbreak profile is defined by an index individual that has recently come into contact with the blood of another mammal through either hunting or the butchering of animal carcasses. Whilst it has been difficult to identify the zoonotic source for the index cases of some outbreaks, a recurring theme of hunting and handling bushmeat is suspected (Table 1;;,; ). For some outbreaks, including the most recent, the initial source of zoonotic transmission has not been identified. In subsequent human-to-human transmission, the highest risk activities are those that bring humans into close contact with infected individuals. These include medical settings where insufficient infection control precautions have been taken, as well as home care and funeral preparations carried out by families or close friends. As the conditions required for transmission are culturally and contextually dependent, opportunities for sustained transmission are highly heterogeneously distributed. Typically, chains of infection do not exceed three or four sequential transmission events, although occasionally (and particularly in the early stages of infection) a single individual may be responsible for directly infecting a large number of others. In the outbreak in Gabon in 1996, a single person was responsible for infecting ten other individuals whilst in the 1995 outbreak in the DRC, thirty five cases resulted from one individual. Secondary transmission can be restricted by effective case detection and isolation measures. Where this cannot be achieved, either due to a lack of infrastructure, poor understanding of the disease, or distrust of medical practices, secondary cases can continue to occur. As the number of infections grows, the ability of healthcare systems to control the further spread diminishes and the risk of a large outbreak increases.
The recent outbreak in Guinea and surrounding countries indicate that the previous paradigm for Ebola outbreaks is shifting. The last 40 years of EVD outbreaks were accompanied by considerable changes in demographic patterns throughout Africa. There has been a large increase in population size coupled with increasing urbanisation. African populations have also become better connected internally and internationally. Only recently have we begun to understand the dynamic nature of these travel patterns which have been clearly demonstrated to influence disease transmission over different temporal and spatial scales. Changes in land use and penetration into previously remote areas of rainforest bring humans into contact with potential new reservoirs, while changes in human mobility and connectivity will likely have profound impacts on the dispersion of Ebola cases during outbreaks. These conditions are thought to have a major role in setting the stage for the current outbreak.
This paper aims to define the areas suitable for zoonotic transmission of Ebolavirus (i.e., those routes defined in Figure 1 excluding human-to-human transmission) through species distribution modelling techniques. The fundamental niche of a species can be conceptualised as the confluence of environmental conditions that support its presence in a particular location. Species distribution models quantitatively describe this niche based on known occurrence records of the organism and their associated environmental conditions, enabling predictions of the likely geographic distribution of the species in other regions. The era of satellites and geographical information systems has made high resolution global data on environmental conditions increasingly available. Species distribution modelling using flexible machine learning approaches have been successfully applied to map the global distributions of disease vectors and pathogens such as dengue, influenza and leishmaniasis.
Previous studies applied the GARP (Genetic Algorithm for Rule-set Production) species distribution modelling approach to the locations of 12 Ebola outbreaks in humans between 1976 and 2002 to map the likely distribution of Ebola viruses and as a mechanism to identify potential reservoir hosts. Here we update and improve the maps of the zoonotic transmission niche of EVD by: (i) incorporating more recent outbreak data from outside the formerly predicted niche of EVD; (ii) integrating for the first time data on outbreaks in primates and the occurrence of the virus in the suspected Old World fruit bat (OWFB) reservoirs; (iii) using new satellite-derived information on bespoke environmental covariates from Africa, including new distribution maps of the OWFB; and (iv) using new increasingly flexible niche mapping techniques in the modelling framework. To elucidate the relevance of these maps for transmission, we have also calculated the population at risk of primary spillover outbreaks from the zoonotic niche of EVD in Africa, and we investigated the changing nature of the populations within this niche.
Reported EVD outbreaks
In total, 23 outbreaks of Ebola virus were identified in humans across Africa, consisting of a hypothesised 30 independent primary infection events (Table 1; Figure 2). These outbreaks span the last 40 years from the first outbreaks in 1976 to the five outbreaks that have occurred since 2010 (Table 1). The locations of the index cases span from West Africa, with the most westerly outbreak ongoing in Guinea, to Gabon, the Republic of Congo (ROC), the DRC, South Sudan and Uganda. Before December 2013, a total of 2322 cases had occurred from Ebolavirus infections, a number already overtaken by the likely underreported current case count of the ongoing outbreak >2250 (Figure 2A). Of the four viruses circulating in Africa, Zaire ebolavirus has been responsible for the most outbreaks (13), followed by Sudan ebolavirus (7) and Bundigbuyo ebolavirus with just two outbreaks in 2007/8 and 2012. Tai Forest has caused one confirmed infection in humans, from which the patient recovered. Although outbreaks have been reported since 1976, there was an absence of reported outbreaks in humans for 15 years between 1979 and 1994 (although antibodies in humans were identified over the period) and the frequency of outbreaks has increased substantially post 2000 (Figure 2A).
Reported Ebola virus infections in animals
A total of 51 surveyed locations reporting infections in animals were identified in the literature since the discovery of the disease (Table 2; Figure 3). These comprised 17 infections in gorillas (Gorilla gorilla), nine infections in chimpanzees (Pan troglodytes), 18 in OWFB and 2 in duikers (Cephalophus spp.). A large proportion of the great ape cases originated from the ROC/Gabon border, coinciding with the main known distributions of both chimpanzees and gorillas and representing a period of well-documented great ape Ebola outbreaks in and around the Lossi Animal Sanctuary. All animal isolations of Ebola viruses have come from countries that have also reported index cases of human outbreaks, with the exception of several seropositive bats from a survey in southern Ghana.
Predicted distribution of suspected reservoir species of bats
Three species of bats, Hypsignathus monstrosus, Myonycteris torquata and Epomops franqueti, were identified as the most likely candidates to be reservoir species for Ebola viruses due to high seroprevalence and the isolation of RNA closely related to Zaire ebolavirus. In total, 239 locations were identified from the Global Biodiversity Information Facility (GBIF): 67 for H. monstrosus (Figure 4A), 52 for M. torquata (Figure 4B) and 120 for E. franqueti (Figure 4C). Distribution models for all three species demonstrated predictive skill (indicated by an area under the curve (AUC) greater than 0.5) as follows: H. monstrosus AUC 0.63 ± 0.04; M. torquata AUC = 0.59 ± 0.04; E. franqueti AUC = 0.58 ± 0.03, n = 50 submodels for all three species. In addition, each species was broadly predicted within its considered expert opinion range (Figure 4A–C). The marginal effect plots (not shown) were strongly influenced by land surface temperature (LST) and vegetation (as measured by the enhanced vegetation index [EVI]). The predicted combined distribution of these species (Figure 4D), covers West and Central Africa, specifically the moist forests of the northeastern, western and central Congo basin, and Guinea, as well as the Congolian coastal forest ecoregions.
Predicted environmental suitability for zoonotic transmission of Ebola
The predicted environmental niche for zoonotic transmission of EVD is shown in Figure 5. All countries with observed index cases of EVD (n = 7, hereafter Set 1) have areas of the highest environmental suitability (see list in Table 1). In addition, areas of high environmental suitability for zoonotic transmission are predicted in a further 15 countries where, to date, index cases of the four African species of Ebolavirus have not been recorded. These are Nigeria, Cameroon, Central African Republic (CAR), Ghana, Liberia, Sierra Leone, Angola, Tanzania, Togo, Ethiopia, Mozambique, Burundi, Equatorial Guinea, Madagascar and Malawi (hereafter Set 2).
The AUC for the Ebola model was relatively high (AUC = 0.85 ± 0.04, n = 500 submodels) indicating that the model could strongly distinguish regions of environmental suitability for EVD. Enhanced vegetation index had the greatest impact on the distribution (relative contribution [RC] of 65.3%) followed by elevation (RC = 11.7%), night-time land surface temperature (LST) (RC = 7.7%), potential evapotranspiration (PET) (RC = 5.7%) and combined bat distribution (RC = 3.8%). Marginal effect plots are presented in Figure 5—figure supplement 2.
In total, 22.2 million people are predicted to live in areas suitable for zoonotic transmission of Ebola. The vast majority, 21.7 million (approximately 97%), live in rural areas, as opposed to urban or peri-urban areas. Of these, 15.2 million are in Set 1 and 7 million are in Set 2. In terms of ranked populations at risk, DRC, Guinea and Uganda are highest in Set 1 and Nigeria, Cameroon and CAR are top in Set 2. For a full listing of these populations living in areas of risk, see the stacked bar plot in Figure 5A.
National level demographic and mobility changes
Over the 40 year period since discovery of EVD, the total population living in those countries predicted to be within the zoonotic niche has nearly tripled (from 230 million to 639 million) and the proportion of the population in these countries living in an urban (rather than rural) setting has changed from 25.5% to 59.2% (Figure 6).
Data on the connectivity of human populations over this period were not available. We can infer however, intuitively, empirically and theoretically that rates of population movement within a country will scale directly in proportion to population growth.
International connectivity by airline traffic
Records of passenger seat capacity are available since 2000 and show substantive increases over the period in Set 1 (from 2.96 to 4.77 million, a fractional change of 1.61) and Set 2 (from 5.6 to 15.6 million, a change of 2.8) (Figure 7A). More specific data on passenger volumes show almost universally similar increases since 2005 with Set 1 nations changing from 2 million to 2.5 million, a fractional change of 1.22 and Set 2 changing from 5 million to 7.9 million, a change of 1.57 (Figure 7B).
Global analysis of airline passenger volumes demonstrates that international connectivity has increased amongst all global regions and national income strata (Figure 8). Total passenger volumes have increased by a third from 9.5 to over 14 million during the eight year window (2005–2012) where records are available. The largest increases have occurred in WHO regions outside of the sub-Saharan African region (AFRO) (Figure 8A,B). In 2012, almost half of the final destinations of those travelling from these at-risk countries were to other AFRO nations (47%). Other frequent destinations were in Europe (EURO; 27%) and the Eastern Mediterranean (EMRO; 13%). Similarly, analysis of passenger volumes by World Bank national income groupings (Figure 8C,D) show that in 2012 40% of all passenger final destinations were to low or low-middle income countries.
Summary of the main findings
We have re-evaluated the zoonotic niche for EVD in Africa. In doing so we have (i) used all existing outbreaks to assemble an inventory of index cases (n = 30); (ii) added to this all confirmed records of Ebola virus in animals (n = 51); (iii) assembled more accurate and contemporary environmental covariates including new maps of the distribution of confirmed OWFB reservoirs of the disease; and (iv) used the latest niche modelling techniques to predict the geographic distribution of potential zoonotic transmission of the disease. Using these predictions we have estimated the populations at risk of EVD both in countries which have confirmed index cases (Set 1, n = 7) and those for which we predict strong environmental suitability for outbreaks (Set 2, n = 15). In all countries at risk we show that since the discovery of EVD in 1976, urban and rural populations have increased and have become more interconnected both within and across national borders. During the last 40 years the increasing size and connectivity of these populations may have facilitated the subsequent spread of EVD outbreaks. These factors underline a change in the way in which EVD interacts with human populations.
Interpreting the zoonotic niche
The remote and isolated nature of Ebola zoonotic transmission events, paired with the relatively poor diagnostics and understanding of the disease transmission routes in early outbreaks, mean that under-reporting of previous outbreaks is probable. An increasing understanding and description of a broader range of symptoms used in case definitions of EVD also increase the possibility that past outbreaks may have been misattributed to different diseases. This poor detectability of EVD also clearly limits capacity to accurately identify the locations and transmission routes of index cases. We must assume, as has been done previously, that the first reported cases are representative of the true location of the index cases. Where possible we have represented this geographic uncertainty by attributing the index case to a wide-area polygon which then incorporated this uncertainty into the mapping process (see ‘Materials and methods’).
The relationship between the EVD niche and the environmental covariates (Figure 5—figure supplement 2), particularly the high relative contribution of the vegetation index, underscore that there are clear environmental limits to transmission of the virus from animals to humans, and that ecoregions dominated by rainforest are the primary home of such zoonotic cycles. Our analysis has shown that the zoonotic niche of the pathogen is more widespread than previously predicted or appreciated, most notably in West Africa.
This analysis used information from all human outbreaks and animal infections to delineate the likely zoonotic niche of the disease. Further analysis, excluding the existing outbreak focussed in Guinea from the dataset used to train the model (Figure 5—figure supplement 3), still resulted in prediction of high suitability in this region, with the presumed index village located within 5 km of an at-risk pixel. This implies that the eco-epidemiological situation in Guinea is very similar to that in past outbreaks, mirroring phylogenetic similarity in the causative viruses. The ecological similarity between the past and current outbreaks also lends support to the notion that the scale of this outbreak is more heavily influenced by patterns of human-to-human transmission than any expansion of the zoonotic niche.
Interpreting population at risk
It is important to appreciate that this zoonotic niche map delineates areas in which populations are at-risk of zoonotic transmission of EVD (Figure 5B). It does not predict the likelihood of EVD spillover, the likelihood of an outbreak establishing, or its subsequent rate of spread within a population. Increasing human encroachment and certain cultural practices sometimes linked with poverty, such as bushmeat hunting, result in increasing exposure of humans to animals which may harbour diseases including Ebola. Increasing human population may accelerate the degree of risk through these processes but spatially refined information on these factors is not available comprehensively. It is hoped that as the understanding of the risk factors for zoonotic transmission of Ebolavirus to humans increases, it will be possible to incorporate this information into future risk mapping assessments.
Previous considerations of the geographic distribution of EVD have used human outbreaks alone. We have updated this work to include the last decade of outbreaks, as well as disaggregated outbreaks where evidence suggests multiple independent zoonotic transmission events overlap in space and time. Furthermore, our modelling process accommodates uncertainty in geopositioning of these index cases by utilising both point and polygon data. In addition, we include occurrence of infection in wildlife, important to the wider scale of zoonotic transmission (Figure 1), which in total has increased the dataset used in the model to 81 occurrences. The rareness of EVD outbreaks and the prevalence of detectable Ebola virus in reservoir species suggests that there will always be a limited set of observation data when compared to mapping of more prevalent zoonoses. The results demonstrate predictive skill using a stringent validation procedure, however, indicating strong model performance even with this relatively limited observation dataset.
A broad zoonotic niche is predicted across 22 countries in Central and West Africa. Whilst several of these countries have reported index cases of EVD, others have not, although serological evidence in some regions points to possible underreporting of small-scale outbreaks. With improved ecological understanding, particularly with improvements to our knowledge of specific reservoir species and their distributions, it may be possible to delineate areas not at risk due to the absence of these species.
Despite relatively a large population living in areas of risk and the widespread practice of bushmeat hunting in these predicted areas, Ebolavirus is rare both in suspected animal reservoirs and in terms of human outbreaks (Table 1). There is some indication however, that the frequency of Ebola outbreaks has increased since 2000, as shown in Figure 2A. We have shown that the human population living within this niche is larger, more mobile and better internationally connected than when the pathogen was first observed. As a result, when spillover events do occur, the likelihood of continued spread amongst the human population is greater, particularly in areas with poor healthcare infrastructure.
Whilst rare in comparison to other high burden diseases prevalent in this region, such as malaria, Ebola outbreaks can have a considerable economic and political impact, and the subsequent destabilisation of basic health care provisioning in affected regions increases the toll of unrecorded morbidity and mortality of more common infectious diseases, throughout and after the epidemic period. The number of concurrent infections during the present outbreak represents a significant strain on healthcare systems that are already poorly provisioned and many other Set 1 and Set 2 countries rank amongst the lowest per capita healthcare spenders. These considerations should be paramount when international organizations debate the financing requirements for the improvement of healthcare needed in the region and the urgency with which new therapeutics and vaccines can be brought into production.
Together, these considerations necessitate prioritisation of efforts to reinforce and improve existing surveillance and control, and encourage the development of therapeutics and vaccines. The national population at risk estimates presented here would be a strong rationale for improving, prioritising and stratifying surveillance for EVD outbreaks and diagnostic capacity in these countries. We believe it would be prudent to test OWFB species in Set 2 countries for Ebola virus, particularly during the bat breeding season to maximise chances of isolation in order to clarify the outbreak risk in these countries. In all Set 1 and Set 2 countries, raising awareness about the risk presented by reservoir bats and incidental primate hosts and the modes of transmission of this disease could be of value. Finally, increasing our capacity to rapidly map ever changing biological threats is also a core need.
Interpreting International connectivity
The increasing connectedness of the Africa region means that EVD is now a problem of international concern. While most EVD secondary transmission occurs locally and is likely transported via ground transit, the potential for international spread of infection is possible, as demonstrated by the importation of the disease from Liberia to Nigeria, culminating in further secondary transmission in Lagos. The aetiology of EVD infection and disease progression means that an international outbreak propagated by air travel remains unlikely, particularly in high-income countries better able to handle EVD cases. Nevertheless, a non-negligible threat remains, particularly in the low and middle income destinations and the rapid increase in global connectivity of these at-risk regions indicates that international airports could see more imported cases.
Future work
We have focussed on reanalysing the zoonotic niche for EVD transmission and the characterisation of the populations at risk to improve the landscape in which future risk and impact of EVD outbreaks can be discussed. During the current emergency much of the work will concentrate on routes of secondary transmission in the human population—conceptually the red arrow of the H box in Figure 1. An important task is to stratify the risk of EVD spread both within and between countries and identify the most likely pathways of spread for characterisation and surveillance. Our next priority therefore is to investigate aspects of secondary human-to-human transmission by documenting the rate of geographic spread of EVD during the past and ongoing epidemics to help understand changes in these patterns in the historical record. Simulating these movements in a real landscape of population movement patterns, inferred from population movements assessed by mobile phones and other data, as well as parametric movement models is a logical next step, and can be used in future targeting of interventions and potential new treatments for both the current and future outbreaks.
As previously discussed, whilst there is the risk of human travel during the latent phase of infection, and therefore potential for international spread, the high pathogenicity during infectiousness (immobilising infected persons) and the likely rapid and effective isolation measures implemented in regions with strong health care systems, limit the pandemic potential of EVD. Nevertheless, improvement of international containment plans and informed discussions of potential risks to airline carriers and populations of other regions will be supported by knowledge of local, regional and international population flows. Assessing these flows by air traffic volumes is an ongoing priority.
There are several other zoonotic viral haemorrhagic fevers (for example Marburgvirus, Lassa fever, hantaviral infections and arenaviruses) that are of similar public health and biosecurity concern, due to their high virulence and mortality and their potential to cause outbreaks and spread internationally. Despite this their geographical distributions are poorly understood. Many of the methods applied here can be adapted to these diseases and improve our geographical understanding of the risk presented by these pathogens.
We are in the midst of a public health emergency that will likely last for many more months and which has brought EVD to global attention. We emphasise that the maps of zoonotic transmission presented here do not enable assessment of secondary transmission rates in human populations, but they do act as an evidenced-based indicator of locations with potential for future zoonotic transmission and thus outbreaks. Interestingly, early reports of another independent zoonotic outbreak in the DRC are in predicted at-risk areas. An improved understanding of the spatial extent of the zoonotic niche can only help future efforts in biosurveillance.
Methodological overview
A boosted regression tree (BRT) modelling framework was used to generate predictive risk maps of the zoonotic Ebola virus niche in Africa. This methodology combines regression trees, where trees are built according to optimal decision rules based on how binary decisions best accommodate a given dataset, and boosting, which selects the tree that minimises the loss function. In doing so, a parameter space is defined which captures the greatest amount of variation present in the dataset. In order to train the model, four component datasets were compiled: (i) a comprehensive dataset of the reported locations of Ebola virus transmission from a zoonotic reservoir to a human; (ii) a dataset of the locations of Ebola virus infections in suspected reservoir and (non-human) susceptible host species (iii) a suite of ecologically relevant environmental covariates for Africa, including predicted distribution maps of suspected reservoir bat species and (iv) background (or pseudo-absence) records representing locations where zoonotic Ebola virus has not been reported. This study was limited to the African continent since no natural outbreaks of EVD have occurred outside the continent. Only Reston ebolavirus has a distribution reported outside of Africa, focussed in the Philippines, but has never been reported as pathogenic in humans; as a result this species was not included in the analysis.
Identifying index cases and reconstructing zoonotic transmission events in space and time
Tables detailing proven outbreaks of Ebola virus, initially sourced from the scientific literature and from health reporting organisations, were used to coordinate searches of the formal scientific literature using Web of Science and PubMed for each specific outbreak. Relevant papers were abstracted and where possible outbreak-specific epidemiological surveys were sourced. The citations in these references were obtained in order to reconstruct the outbreak in detail and to identify the most probable index case. Index cases were defined as any human infection resulting from interaction with non-human sources of the disease. Some of these cases arose from presumed interactions with zoonotic reservoirs or hosts, such as primates and other mammals during hunting trips (;,; WHO, 2003) or butchering of bats. Any cases arising from existing human infections are considered as secondary infections rather than index cases. Similar to methodology employed elsewhere, the site, or supposed site, of this zoonotic transmission event was geopositioned using Google Earth. For locations where precise geographic information (e.g., geographic coordinates of a hunting camp) was provided by the authors, these were used. Where precise geographic information could not be accurately geopositioned, a geographic area (termed a polygon) was defined covering the reported region. In several cases only the first reported patient could be identified, with the source of infection unknown. With these outbreaks the location of the first patient was geopositioned under the assumption that an initial zoonotic spillover event occurred in the vicinity of this location. In two outbreaks multiple independent zoonotic transmission events were identified (WHO, 2003;; ), and each unique event was geopositioned and included in the model as separate entities. Table 1 catalogues the outbreaks used in this study.
Assembling a database of reported infections in animals
A literature search was conducted in Web of Science using the search term “Ebola” that returned 8635 citations. The abstracts were examined and for those that contained possible data on animal Ebola infection, the full text was obtained. The sampling site or location of the animal in the study was identified and geopositioned using Google Maps. These locations were recorded either as precise locations or as polygons, as with human index cases. Records for which local transmission of Ebola virus was deemed unlikely (e.g., seropositive primates tested in containment facilities several years after their capture) were excluded from the study. The non-human Ebola virus occurrence data collected are detailed in Table 2, including the diagnostic methods used.
GenBank isolates
The open access sequence database GenBank was searched using MESH Umbrella search terms for Ebola virus, returning 181 results. These were then manually cross-referenced with the existing human and animal Ebola information, collected above, and 30 duplicates were removed. For the remaining isolates, original references and GenBank information fields were examined, but as there was insufficient information to establish precise location of isolation and/or whether the isolate represented an index case for any of these data sources, they were excluded from subsequent analyses.
Covariates assembled and used in the analyses
A suite of ecologically relevant gridded environmental covariates for Africa was compiled, each having a nominal resolution of 5 km × 5 km. The environmental covariates used in this analysis were: elevation (from the shuttle radar topography mission); the mean value, and a measure of spatial variation (range, described below) between 2000 and 2012 of Enhanced Vegetation Index (EVI), daytime Land Surface Temperature (LST) and night-time LST; and mean potential evapotranspiration from 1950–2000 (Figure 5—figure supplement 1).
The EVI and LST datasets were derived from satellite imagery collected by NASA's Moderate Resolution Imaging Spectroradiometer (MODIS) remote sensing platform. EVI is a metric designed to characterise vegetation density and vigour based on the ratio of absorbed photosynthetically active radiation to near infrared radiation. LST is a modelled product derived from emissivity as measured by the MODIS thermal sensor, which is correlated, though not synonymous with air temperature, and effective for differentiating landscapes based on a combination of thermal energy and properties of surface types. The MODIS datasets utilized in this research (EVI was derived from the MCD43B4 product and the MOD11A2 LST product was used directly) were acquired as composite datasets created using imagery collected over multiple days, a procedure that results in products with 8-day temporal resolutions. Despite compositing, the EVI and LST datasets contained gaps due to persistent cloud cover found in forested equatorial regions, and these gaps were filled using a previously described approach. The EVI and LST datasets were then aggregated from their native 1 km × 1 km spatial resolution to a final 5 km × 5 km resolution, calculating both the mean and the range of the values of the subpixels making up each larger pixel. These spatial summaries therefore characterise both the mean temperature in each location as well as the degree of spatial heterogeneity within that pixel. This is of interest as humans and susceptible species are more likely to come into contact in transitional areas (e.g., boundary areas between areas of highly suitable susceptible species habitat and areas heavily utilised by humans). The final covariate production step consisted of summarising temporally across the 13-year data archive to produce synoptic datasets devoid of annual or seasonal anomalies.
Implicated bat reservoir distributions
Over recent years, significant research has been undertaken in investigating the role bats have to play in the transmission cycle of Ebola viruses and evidence of asymptomatic infection in fruit bats has been documented to varying extents. In order to incorporate this potential driver of Ebola virus transmission into the model we developed predicted distribution maps for three species of fruit bat implicated as primary reservoirs of the disease: Hypsignathus monstrosus, Epomops franqueti and Myonycteris torquata. The evidence was strongest for these three species having a reservoir role as Ebola virus RNA (all nested within the Zaire ebolavirus phylogeny) has been detected in all three. Whilst a handful of other bat species have been found to be seropositive, no further viral isolations have been recorded.
Whilst expert opinion range maps for these species exist, there is some disagreement with independently-sourced occurrence data (all archived in the Global Biodiversity Information Facility). As a result, a predictive modelling approach was used to create a continuous surface of habitat suitability for these species which we then included as a predictor in the model. Occurrence data for all Megachiroptera in Africa was extracted from GBIF using the R packages dismo and taxize. To remove apparently erroneous records in the GBIF archive all occurrence records more than 100 km from the species known ranges, as determined by expert-opinion range maps, were excluded, as were duplicate records and those located in the ocean. This resulted in a total dataset of 1341 unique occurrence records.
The occurrence database was then used to train separate boosted regression tree species distribution models to predict the likely distribution of each of these suspected reservoir species. For each model, occurrence records for the target species (H. monstrosus, n = 67; E. franqueti, n = 120; and M. torquata, n = 52) were considered presence records and occurrence records of all other species were used as background records. This procedure is designed to account for the potentially biasing effect of spatial variation in recording of Megachiroptera occurrences.
For each species we ran fifty submodels each trained to a randomly selected bootstrap of this dataset, subject to the constraint that each bootstrap contained a minimum of 10 occurrence and 10 background records. Each submodel was fitted using the gbm.step subroutine in the dismo R package. In each submodel the background records were down weighted so that the weighted sum of presence records equalled the weighted sum of background records in order to maximise the discrimination capacity of the model. We generated a prediction map from each of these submodels and calculated both the mean prediction and 95% confidence interval around the prediction for each 5 km × 5 km pixel for each species.
Model accuracy was assessed by calculating the mean area under the curve (AUC) statistic for each submodel under a stringent 10-fold cross validation for each submodel and obtaining the mean and standard deviation across all 50 submodels. Under this procedure the dataset was split into ten subsets, each containing approximately equal numbers of presence and background points. The ability of a model trained on each subset to predict the distribution of the other 90% of records was assessed by AUC and the mean value taken. As so few presence records were used to train each fold model (i.e., around 5 presence records for M. torquata up to 12 for E. franqueti), this represents a very stringent test of the model's predictive capacity. Additionally, to prevent inflation of the accuracy statistics due to spatial sorting bias, these statistics were estimated using a pairwise distance sampling procedure. Consequently, the AUC statistics presented here are lower than would be returned by standard procedures but gives a more realistic quantification of the model's ability to extrapolate predictions to new regions. We also generated marginal effect plots with associated uncertainty intervals and relative contribution statistics (how often each covariate was selected during the model fitting process) as quantification of the sensitivity of the model to the different covariates. These allow us to make inferences about the ecological relationship between each species and its environment as well as to identify where this relationship is most uncertain.
To generate a single surface describing the distribution of the bat reservoir species to be used as a covariate in the subsequent Ebola modelling, the three mean prediction distribution maps were merged by taking the average habitat suitability for each of the three bat species at each pixel.
Ebola distribution modelling
The Ebola virus occurrence dataset was supplemented with a background record dataset generated by randomly sampling 10,000 locations across Africa, biased towards more populous areas as a proxy for reporting bias. We fitted 500 submodels to bootstraps of this dataset. To account for uncertainty in the geographic location of those occurrences reported as polygons, for each submodel one point was randomly selected from each of these occurrence polygons. This Monte Carlo procedure enabled the model to efficiently integrate over the environmental uncertainty associated with imprecise geographic data. A bootstrap sample was then taken from each of these datasets and used to train the BRT model using the same procedure and weighting of background records as for the bat distribution models. Similarly, we generated a prediction map from each of these models and calculated both the mean prediction and corresponding 95% confidence intervals for each pixel and analysed prediction accuracy using the same stringent cross validation and sensitivity analysis procedure as for the bat distribution models (detailed above).
The predicted distribution map produced by this approach represents the environmental suitability of each pixel for zoonotic Ebola virus transmission. This may be interpreted as a relative probability of presence in the sense that more suitable pixels are more likely to contain zoonotic transmission than less suitable pixels, though not an absolute probability that transmission occurs in a given pixel. Similarly, the presence of zoonotic transmission increases the risk of transmission to a human, though this is also contingent on how humans interact with these zoonotic pools, through hunting or other activities.
Population living in areas of environmental suitability for zoonotic transmission
In order to identify areas which are likely to be at risk of transmission of Ebolavirus from zoonotic reservoir hosts to humans, the continuous map of the predicted environmental suitability for zoonotic transmission (shown in Figure 5) was converted into a binary map classifying pixels as either at risk or not at risk. A pixel was assumed to be at risk if its predicted environmental suitability for zoonotic Ebola virus transmission was greater than 0.673, the lowest suitability value predicted at the locations of known transmission to humans (point records of human index cases). Countries containing at least one at-risk pixel are shown in Figure 5B—those countries that previously report an index case were defined as Set 1; countries with at least one at-risk pixel with no previous index cases of EVD were categorised as Set 2. The number of people living in at-risk areas in each of these countries was calculated by summing the estimated population of at-risk pixels using population density maps from the AfriPop project and the proportion of those living in urban, periurban and rural areas was evaluated using the Global Rural Urban Mapping Project.
The R code used for all of the analysis has been made available on an open source basis (https://github.com/SEEG-Oxford/ebola_zoonotic).
National level demographic and mobility data
For three separate years (1976, 2000 and 2014), total national populations were retrieved and the proportion of rural to urban populations noted from World Bank statistics. To describe global air travel patterns from Set 1 and Set 2 countries, flight schedules data from the Official Airline Guide, reflecting an estimated 95% of all commercial flights worldwide, were analysed between 2000 and 2013 to calculate the annual volume of seats on direct flights that depart from each predicted country and which have an international destination. Complementing these seat capacity data, worldwide data on anonymised, individual passenger flight itineraries from the International Air Transport Association (2012) were analysed between 2005 and 2012 to calculate the annual volume of international passenger departures out of each Set 1 and Set 2 country. The IATA dataset represents an estimated 93% of the world's commercial air traffic at the passenger level and includes points of departure and arrival and final destination information for travellers as well as their connecting flights.
References 156
- 1.
Amblard J Obiang P Edzang S Prehaud C Bouloy M Guenno BL 1997 Identification of the Ebola virus in Gabon in 1994. Lancet349:181–182
Not in our library10.1016/s0140-6736(05)60984-1
- 2.
Baize S Pannetier D Oestereich L Rieger T Koivogui L Magassouba N Soropogui B Sow MS Keïta S De Clerck H Tiffany A Dominguez G Loua M Traoré A Kolié M Malano ER Heleze E Bocquin A Mély S Raoul H Caro V Cadar D Gabriel M Pahlmann M Tappe D Schmidt-Chanasit J Impouma B Diallo AK Formenty P Van Herp M Günther S 2014 Emergence of Zaire Ebola virus disease in Guinea - preliminary report. The New England Journal of Medicine
Not in our library10.1056/nejmoa1404505
- 3.
Bannister B 2010 Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. British Medical Bulletin95:193–225
Not in our library10.1093/bmb/ldq022
- 4.
Barbet-Massin M Jiguet F Albert CH Thuiller W 2012 Selecting pseudo-absences for species distribution models: how, where and how many?Methods in Ecology and Evolution3:327–338
Not in our library10.1111/j.2041-210x.2011.00172.x
- 5.
Baron RC McCormick JB Zubeir OA 1983 Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bulletin of the World Health Organization61:997–1003
Not in our library
- 6.
Barrette RW Metwally SA Rowland JM Xu LZ Zaki SR Nichol ST Rollin PE Towner JS Shieh WJ Batten B Sealy TK Carrillo C Moran KE Bracht AJ Mayr GA Sirios-Cruz M Catbagan DP Lautner EA Ksiazek TG White WR McIntosh MT 2009 Discovery of swine as a host for the Reston ebolavirus. Science325:204–206
Not in our library10.1126/science.1172705
- 7.
- 8.
Beer B Kurth R Bukreyev A 1999 Characteristics of Filoviridae: Marburg and Ebola viruses. Die Naturwissenschaften86:8–17
Not in our library10.1007/s001140050562
- 9.
Bermejo M Rodríguez-Teijeiro JD Illera G Barroso A Vilà C Walsh PD 2006 Ebola outbreak killed 5000 gorillas. Science314:1564
Not in our library10.1126/science.1133105
- 10.
Bhatt S Gething PW Brady OJ Messina JP Farlow AW Moyes CL Drake JM Brownstein JS Hoen AG Sankoh O Myers MF George DB Jaenisch T Wint GR Simmons CP Scott TW Farrar JJ Hay SI 2013 The global distribution and burden of dengue. Nature496:504–507
Not in our library10.1038/nature12060
- 11.
Boumandouki P Formenty P Epelboin A Campbell P Atsangandoko C Allarangar Y Leroy EM Kone ML Molamou A Dinga-Longa O Salemo A Kounkou RY Mombouli V Ibara JR Gaturuku P Nkunku S Lucht A Feldmann H 2005 [Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo]. Bulletin de la Société de Pathologie Exotique98:218–223
Not in our library
- 12.
Brady OJ Hay SI Horby P 2014 Estimating vaccine and drug requirements for Ebola outbreaks. Nature512:7514
Not in our library10.1038/512233a
- 13.
Brashares JS Golden CD Weinbaum KZ Barrett CB Okello GV 2011 Economic and geographic drivers of wildlife consumption in rural Africa. Proceedings of the National Academy of Sciences of USA108:13931–13936
Not in our library10.1073/pnas.1011526108
- 14.
Briand S Bertherat E Cox P Formenty P Kieny MP Myhre JK Roth C Shindo N Dye C 2014 The international Ebola emergency. The New England Journal of Medicine
Not in our library10.1056/nejmp1409858
- 15.
Brockmann D Helbing D 2013 The hidden geometry of complex, network-driven contagion phenomena. Science342:1337–1342
Not in our library10.1126/science.1245200
- 16.
Caillaud D Levréro F Cristescu R Gatti S Dewas M Douadi M Gautier-Hion A Raymond M Ménard N 2006 Gorilla susceptibility to Ebola virus: the cost of sociality. Current Biology16:R489–R491
Not in our library10.1016/j.cub.2006.06.017
- 17.
CDC 2014 Chronology of Ebola hemorrhagic fever outbreaks. Accessed: August 2014. Available: http://www.cdc.gov/vhf/ebola/resources/outbreak-table.html
Not in our library
- 18.
Chamberlain S Szocs E Boettiger C Ram K Bartomeus I Baumgartner J 2014 taxize: taxonomic information from around the web. R package. Accessed: August 2014. Available: https://github.com/ropensci/taxize
Not in our library
- 19.
Chan M 2014 Ebola virus disease in West Africa - no early end to the outbreak. The New England Journal of Medicineonline
Not in our library
- 20.
Chowell G Hengartner NW Castillo-Chavez C Fenimore PW Hyman JM 2004 The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. Journal of Theoretical Biology229:119–126
Not in our library10.1016/j.jtbi.2004.03.006
- 21.
CIESIN/IFPRI/WB/CIAT 2007 Global Rural Urban Mapping Project (GRUMP): gridded population of the world, version 3. Accessed: December 2013. Available: http://sedac.ciesin.columbia.edu/gpw
Not in our library
- 22.
Cohen B 2004 Urban growth in developing countries: a review of current trends and a caution regarding existing forecasts. World Development32:23–51
Not in our library10.1016/j.worlddev.2003.04.008
- 23.
Conrad JL Isaacson M Smith EB Wulff H Crees M Geldenhuys P Johnston J 1978 Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. The American Journal of Tropical Medicine and Hygiene27:1210–1215
Not in our library10.4269/ajtmh.1978.27.1210
- 24.
Daszak P 2000 Emerging infectious diseases of wildlife - threats to biodiversity and human health. Science287:443–449
Not in our library10.1126/science.287.5452.443
- 25.
De'ath G 2007 Boosted trees for ecological modeling and prediction. Ecology88:243–251
Not in our library10.1890/0012-9658(2007)88[243:btfema]2.0.co;2
- 26.
Dudas G Rambaut A 2014 Phylogenetic analysis of Guinea 2014 EBOV ebolavirus outbreak. PLOS Currents6:ecurrents.outbreaks.84eefe85ce43ec89dc80bf0670f0677b0678b0417d
Not in our library10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d
- 27.
ECDC 2014 Outbreak of Ebola virus disease in West Africa. Stockholm: ECDC p. 17
Not in our library
- 28.
Elith J Leathwick JR 2009 Species distribution models: ecological explanation and prediction across space and time. Annual Review of Ecology, Evolution, and Systematics40:677–697
Not in our library10.1146/annurev.ecolsys.110308.120159
- 29.
Elith J Leathwick JR Hastie T 2008 A working guide to boosted regression trees. The Journal of Animal Ecology77:802–813
Not in our library10.1111/j.1365-2656.2008.01390.x
- 30.
Fauci AS 2014 Ebola - underscoring the global disparities in health care resources. The New England Journal of Medicine
Not in our library10.1056/nejmp1409494
- 31.
Feldmann H Geisbert TW 2011 Ebola haemorrhagic fever. Lancet377:849–862
Not in our library10.1016/s0140-6736(10)60667-8
- 32.
Formenty P Boesch C Wyers M Steiner C Donati F Dind F Walker F Le Guenno B 1999 Ebola virus outbreak among wild chimpanzees living in a rain forest of Cote d'Ivoire. The Journal of Infectious Diseases179(suppl 1):S120–S126
Not in our library10.1086/514296
- 33.
- 34.
Franklin J 2009 Mapping species distributions. Cambridge: Cambridge University Press p. 320
Not in our library
- 35.
Garcia AJ Pindolia DK Lopiano KK Tatem AJ 2014 Modeling internal migration flows in sub-Saharan Africa using census microdata. Migration Studiesin press
Not in our library10.1093/migration/mnu036
- 36.
GBIF 2014 Global biodiversity information facility. Accessed: August 2014. Available: http://www.gbif.org/
Not in our library
- 37.
Gear JS Cassel GA Gear AJ Trappler B Clausen L Meyers AM Kew MC Bothwell TH Sher R Miller GB Schneider J Koornhof HJ Gomperts ED Isaäcson M Gear JH 1975 Outbreake of Marburg virus disease in Johannesburg. British Medical Journal4:489–493
Not in our library10.1136/bmj.4.5995.489
- 38.
Georges AJ Leroy EM Renaut AA Benissan CT Nabias RJ Ngoc MT Obiang PI Lepage JP Bertherat EJ Bénoni DD Wickings EJ Amblard JP Lansoud-Soukate JM Milleliri JM Baize S Georges-Courbot MC 1999 Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. The Journal of Infectious Diseases179:S65–S75
Not in our library10.1086/514290
- 39.
Georges-Courbot MC Sanchez A Lu CY Baize S Leroy E Lansout-Soukate J Tévi-Bénissan C Georges AJ Trappier SG Zaki SR Swanepoel R Leman PA Rollin PE Peters CJ Nichol ST Ksiazek TG 1997 Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerging Infectious Diseases3:59–62
Not in our library10.3201/eid0301.970107
- 40.
- 41.
- 42.
Gire SK Goba A Andersen KG Sealfon RSG Park DJ Kanneh L Jalloh S Momoh M Fullah M Dudas G Wohl S Moses LM Yozwiak NL Winnicki S Matranga CB Malboeuf CM Qu J Gladden AD Schaffner SF Yang X Jiang PP Nekoui M Colubri A Coomber MR Fonnie M Moigboi A Gbakie M Kamara FK Tucker V Konuwa E Saffa S Sellu J Jalloh AA Kovoma A Koninga J Mustapha I Kargbo K Foday M Yillah M Kanneh F Robert W Massally JLB Chapman SB Bochicchio J Murphy C Nusbaum C Young S Birren BW Grant DS Scheiffelin JS Lander ES Happi C Gevao SM Gnirke A Rambaut A Garry RF Khan SH Sabeti PC 2014 Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science345:1369–1372
Not in our library10.1126/science.1259657
- 43.
Gonzalez MC Hidalgo CA Barabasi AL 2008 Understanding individual human mobility patterns. Nature453:779–782
Not in our library10.1038/nature06958
- 44.
Goodman JL 2014 Studying “secret serums” - toward safe, effective Ebola treatments. The New England Journal of Medicine.
Not in our library10.1056/nejmp1409817
- 45.
Gostin LO Lucey D Phelan A 2014 The ebola epidemic: a global health emergency. JAMAE1–E2
Not in our library10.1001/jama.2014.11176
- 46.
Grard G Biek R Tamfum JJM Fair J Wolfe N Formenty P Paweska J Leroy E 2011 Emergence of divergent Zaire Ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. The Journal of Infectious Diseases204:S776–S784
Not in our library10.1093/infdis/jir364
- 47.
Groseth A Feldmann H Strong JE 2007 The ecology of Ebola virus. Trends in Microbiology15:408–416
Not in our library10.1016/j.tim.2007.08.001
- 48.
- 49.
Hay SI George DB Moyes CL Brownstein JS 2013b Big data opportunities for global infectious disease surveillance. PLOS Medicine10:e1001413
Not in our library10.1371/journal.pmed.1001413
- 50.
Hay SI Tatem AJ Graham AJ Goetz SJ Rogers DJ 2006 Global environmental data for mapping infectious disease distribution. Advances in Parasitology62:37–77
Not in our library10.1016/s0065-308x(05)62002-7
- 51.
Hayman DT Emmerich P Yu M Wang LF Suu-Ire R Fooks AR Cunningham AA Wood JL 2010 Long-term survival of an urban fruit bat seropositive for Ebola and Lagos Bat viruses. PLOS ONE5:e11978
Not in our library10.1371/journal.pone.0011978
- 52.
Hayman DT Yu M Crameri G Wang LF Suu-Ire R Wood JL Cunningham AA 2012 Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerging Infectious Diseases18:1207–1209
Not in our library10.3201/eid1807.111654
- 53.
Hewlett BS Epelboin A Hewlett BL Formenty P 2005 Medical anthropology and Ebola in Congo: cultural models and humanistic care. Bulletin de la Société de Pathologie Exotique98:230–236
Not in our library
- 54.
Heymann DL Weisfeld JS Webb PA Johnson KM Cairns T Berquist H 1980 Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. The Journal of Infectious Diseases142:372–376
Not in our library10.1093/infdis/142.3.372
- 55.
Hijmans RJ 2012 Cross-validation of species distribution models: removing spatial sorting bias and calibration with a null model. Ecology93:679–688
Not in our library10.1890/11-0826.1
- 56.
Hijmans RJ Phillips S Leathwick J Elith J 2014 dismo. R package. Accessed: August 2014. Available: http://cran.r-project.org/web/packages/dismo/dismo.pdf
Not in our library
- 57.
Huang ZJ Tatem AJ 2013 Global malaria connectivity through air travel. Malaria Journal12:269
Not in our library10.1186/1475-2875-12-269
- 58.
Huete A Didan K Miura T Rodriguez EP Gao X Ferreira LG 2002 Overview of the radiometric and biophysical performance of the MODIS vegetation indices. Remote Sensing of Environment83:195–213
Not in our library10.1016/s0034-4257(02)00096-2
- 59.
Hufnagel L Brockmann D Geisel T 2004 Forecast and control of epidemics in a globalized world. Proceedings of the National Academy of Sciences of USA101:15124–15129
Not in our library10.1073/pnas.0308344101
- 60.
IATA 2014 International Air Transport Association. Accessed: August 2014. Available: http://www.iata.org/Pages/default.aspx
Not in our library
- 61.
International Commission 1978 Ebola haemorrhagic fever in Zaire, 1976. Bulletin of the World Health Organization56:271–293
Not in our library
- 62.
Jahrling PB Geisbert TW Dalgard DW Johnson ED Ksiazek TG Hall WC Peters CJ 1990 Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet335:502–505
Not in our library10.1016/0140-6736(90)90737-p
- 63.
Jones KE Patel NG Levy MA Storeygard A Balk D Gittleman JL Daszak P 2008 Global trends in emerging infectious diseases. Nature451:990–994
Not in our library10.1038/nature06536
- 64.
Kamins AO Restif O Ntiamoa-Baidu Y Suu-Ire R Hayman DT Cunningham AA Wood JL Rowcliffe JM 2011 Uncovering the fruit bat bushmeat commodity chain and the true extent of fruit bat hunting in Ghana, West Africa. Biological Conservation144:3000–3008
Not in our library10.1016/j.biocon.2011.09.003
- 65.
Karesh WB Dobson A Lloyd-Smith JO Lubroth J Dixon MA Bennett M Aldrich S Harrington T Formenty P Loh EH Machalaba CC Thomas MJ Heymann DL 2012 Ecology of zoonoses: natural and unnatural histories. Lancet380:1936–1945
Not in our library10.1016/s0140-6736(12)61678-x
- 66.
Khan AS Tshioko FK Heymann DL Le Guenno B Nabeth P Kerstiëns B Fleerackers Y Kilmarx PH Rodier GR Nkuku O Rollin PE Sanchez A Zaki SR Swanepoel R Tomori O Nichol ST Peters CJ Muyembe-Tamfum JJ Ksiazek TG 1999 The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. The Journal of Infectious Diseases179:S76–S86
Not in our library10.1086/514306
- 67.
King AMQ Adams MJ Carstens EB Lefkowitz E 2012 Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses. London: Elsevier p. 1338
Not in our library
- 68.
Kuhn JH 2008 Filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies. Vienna: Springer-Verlag p. 413
Not in our library
- 69.
Kuhn JH Becker S Ebihara H Geisbert TW Johnson KM Kawaoka Y Lipkin WI Negredo AI Netesov SV Nichol ST Palacios G Peters CJ Tenorio A Volchkov VE Jahrling PB 2010 Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of Virology155:2083–2103
Not in our library10.1007/s00705-010-0814-x
- 70.
Lahm SA Kombila M Swanepoel R Barnes RF 2007 Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Transactions of the Royal Society of Tropical Medicine and Hygiene101:64–78
Not in our library10.1016/j.trstmh.2006.07.002
- 71.
Lamunu M Lutwama JJ Kamugisha J Opio A Nambooze J Ndayimirije N Okware S 2004 Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001). International Journal of Infectious Diseases8:27–37
Not in our library10.1016/j.ijid.2003.04.001
- 72.
Larkin M 2003 Ebola outbreak in the news. The Lancet Infectious Diseases3:255
Not in our library10.1016/s1473-3099(03)00584-x
- 73.
Le Guenno B Formenty P Wyers M Gounon P Walker F Boesch C 1995 Isolation and partial characterization of a new strain of Ebola virus. Lancet345:1271–1274
Not in our library10.1016/s0140-6736(95)90925-7
- 74.
Legrand J Grais RF Boelle PY Valleron AJ Flahault A 2007 Understanding the dynamics of Ebola epidemics. Epidemiology and Infection135:610–621
Not in our library10.1017/s0950268806007217
- 75.
Leroy EM Baize S Volchkov VE Fisher-Hoch SP Georges-Courbot MC Lansoud-Soukate J Capron M Debré P McCormick JB Georges AJ 2000 Human asymptomatic Ebola infection and strong inflammatory response. Lancet355:2210–2215
Not in our library10.1016/s0140-6736(00)02405-3
- 76.
Leroy EM Epelboin A Mondonge V Pourrut X Gonzalez JP Muyembe-Tamfum JJ Formenty P 2009 Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne and Zoonotic Diseases9:723–728
Not in our library10.1089/vbz.2008.0167
- 77.
Leroy EM Kumulungui B Pourrut X Rouquet P Hassanin A Yaba P Délicat A Paweska JT Gonzalez JP Swanepoel R 2005 Fruit bats as reservoirs of Ebola virus. Nature438:575–576
Not in our library10.1038/438575a
- 78.
Leroy EM Souquière S Rouquet P Drevet D 2002 Re-emergence of ebola haemorrhagic fever in Gabon. Lancet359:712–712
Not in our library10.1016/s0140-6736(02)07796-6
- 79.
- 80.
Linard C Tatem AJ Gilbert M 2013 Modelling spatial patterns of urban growth in Africa. Applied Geography44:23–32
Not in our library10.1016/j.apgeog.2013.07.009
- 81.
- 82.
Messina JP Brady OJ Pigott DM Brownstein JS Hoen AG Hay SI 2014 A global compendium of human dengue virus occurrence. Scientific Data1:140004
Not in our library10.1038/sdata.2014.4
- 83.
Mfunda IM Røskaft E 2010 Bushmeat hunting in Serengeti, Tanzania: an important economic activity to local people. International Journal of Biodiversity and Conservation2:263–272
Not in our library
- 84.
Milleliri JM Tevi-Benissan C Baize S Leroy E Georges-Courbot MC 2004 [Epidemics of Ebola haemorrhagic fever in Gabon (1994-2002). Epidemiologic aspects and considerations on control measures]. Bulletin de la Société de Pathologie Exotique97:199–205
Not in our library
- 85.
Miranda ME White ME Dayrit MM Hayes CG Ksiazek TG Burans JP 1991 Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet337:425–426
Not in our library10.1016/0140-6736(91)91199-5
- 86.
MSF 2014 Ebola epidemic confirmed in Democratic Republic of Congo: MSF sends specialists and material to the epicentre. Accessed: August 2014. Available: http://www.msf.org/article/ebola-epidemic-confirmed-democratic-republic-congo-msf-sends-specialists-and-material
Not in our library
- 87.
Murray CJ Ortblad KF Guinovart C Lim SS Wolock TM Roberts DA Dansereau EA Graetz N Barber RM Brown JC Wang H Duber HC Naghavi M Dicker D Dandona L Salomon JA Heuton KR Foreman K Phillips DE Fleming TD Flaxman AD Phillips BK Johnson EK Coggeshall MS Abd-Allah F Abera SF Abraham JP Abubakar I Abu-Raddad LJ Abu-Rmeileh NM Achoki T Adeyemo AO Adou AK Adsuar JC Agardh EE Akena D Al Kahbouri MJ Alasfoor D Albittar MI Alcalá-Cerra G Alegretti MA Alemu ZA Alfonso-Cristancho R Alhabib S Ali R Alla F Allen PJ Alsharif U Alvarez E Alvis-Guzman N Amankwaa AA Amare AT Amini H Ammar W Anderson BO Antonio CA Anwari P Arnlöv J Arsenijevic VS Artaman A Asghar RJ Assadi R Atkins LS Badawi A Balakrishnan K Banerjee A Basu S Beardsley J Bekele T Bell ML Bernabe E Beyene TJ Bhala N Bhalla A Bhutta ZA Abdulhak AB Binagwaho A Blore JD Bose D Brainin M Breitborde N Castañeda-Orjuela CA Catalá-López F Chadha VK Chang JC Chiang PP Chuang TW Colomar M Cooper LT Cooper C Courville KJ Cowie BC Criqui MH Dandona R Dayama A De Leo D Degenhardt L Del Pozo-Cruz B Deribe K Des Jarlais DC Dessalegn M Dharmaratne SD Dilmen U Ding EL Driscoll TR Durrani AM Ellenbogen RG Ermakov SP Esteghamati A Faraon EJ Farzadfar F Fereshtehnejad SM Fijabi DO Forouzanfar MH Fra Paleo U Gaffikin L Gamkrelidze A Gankpé FG Geleijnse JM Gessner BD Gibney KB Ginawi IA Glaser EL Gona P Goto A Gouda HN Gugnani HC Gupta R Gupta R Hafezi-Nejad N Hamadeh RR Hammami M Hankey GJ Harb HL Haro JM Havmoeller R Hay SI Hedayati MT Pi IB Hoek HW Hornberger JC Hosgood HD Hotez PJ Hoy DG Huang JJ Iburg KM Idrisov BT Innos K Jacobsen KH Jeemon P Jensen PN Jha V Jiang G Jonas JB Juel K Kan H Kankindi I Karam NE Karch A Karema CK Kaul A Kawakami N Kazi DS Kemp AH Kengne AP Keren A Kereselidze M Khader YS Khalifa SE Khan EA Khang YH Khonelidze I Kinfu Y Kinge JM Knibbs L Kokubo Y Kosen S Defo BK Kulkarni VS Kulkarni C Kumar K Kumar RB Kumar GA Kwan GF Lai T Balaji AL Lam H Lan Q Lansingh VC Larson HJ Larsson A Lee JT Leigh J Leinsalu M Leung R Li Y Li Y De Lima GM Lin HH Lipshultz SE Liu S Liu Y Lloyd BK Lotufo PA Machado VM Maclachlan JH Magis-Rodriguez C Majdan M Mapoma CC Marcenes W Marzan MB Masci JR Mashal MT Mason-Jones AJ Mayosi BM Mazorodze TT Mckay AC Meaney PA Mehndiratta MM Mejia-Rodriguez F Melaku YA Memish ZA Mendoza W Miller TR Mills EJ Mohammad KA Mokdad AH Mola GL Monasta L Montico M Moore AR Mori R Moturi WN Mukaigawara M Murthy KS Naheed A Naidoo KS Naldi L Nangia V Narayan KM Nash D Nejjari C Nelson RG Neupane SP Newton CR Ng M Nisar MI Nolte S Norheim OF Nowaseb V Nyakarahuka L Oh IH Ohkubo T Olusanya BO Omer SB Opio JN Orisakwe OE Pandian JD Papachristou C Caicedo AJ Patten SB Paul VK Pavlin BI Pearce N Pereira DM Pervaiz A Pesudovs K Petzold M Pourmalek F Qato D Quezada AD Quistberg DA Rafay A Rahimi K Rahimi-Movaghar V Rahman SU Raju M Rana SM Razavi H Reilly RQ Remuzzi G Richardus JH Ronfani L Roy N Sabin N Saeedi MY Sahraian MA Samonte GM Sawhney M Schneider IJ Schwebel DC Seedat S Sepanlou SG Servan-Mori EE Sheikhbahaei S Shibuya K Shin HH Shiue I Shivakoti R Sigfusdottir ID Silberberg DH Silva AP Simard EP Singh JA Skirbekk V Sliwa K Soneji S Soshnikov SS Sreeramareddy CT Stathopoulou VK Stroumpoulis K Swaminathan S Sykes BL Tabb KM Talongwa RT Tenkorang EY Terkawi AS Thomson AJ Thorne-Lyman AL Towbin JA Traebert J Tran BX Dimbuene ZT Tsilimbaris M Uchendu US Ukwaja KN Vallely AJ Vasankari TJ Venketasubramanian N Violante FS Vlassov VV Waller S Wallin MT Wang L Wang SX Wang Y Weichenthal S Weiderpass E Weintraub RG Westerman R White RA Wilkinson JD Williams TN Woldeyohannes SM Wong JQ Xu G Yang YC Yano Y Yip P Yonemoto N Yoon SJ Younis M Yu C Jin KY El Sayed Zaki M Zhao Y Zheng Y Zhou M Zhu J Zou XN Lopez AD Vos T 2014 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet
Not in our library10.1016/s0140-6736(14)60844-8
- 88.
Murray CJL Vos T Lozano R Naghavi M Flaxman AD Michaud C Ezzati M Shibuya K Salomon JA Abdalla S Aboyans V Abraham J Ackerman I Aggarwal R Ahn SY Ali MK Alvarado M Anderson HR Anderson LM Andrews KG Atkinson C Baddour LM Bahalim AN Barker-Collo S Barrero LH Bartels DH Basáñez MG Baxter A Bell ML Benjamin EJ Bennett D Bernabé E Bhalla K Bhandari B Bikbov B Bin Abdulhak A Birbeck G Black JA Blencowe H Blore JD Blyth F Bolliger I Bonaventure A Boufous S Bourne R Boussinesq M Braithwaite T Brayne C Bridgett L Brooker S Brooks P Brugha TS Bryan-Hancock C Bucello C Buchbinder R Buckle G Budke CM Burch M Burney P Burstein R Calabria B Campbell B Canter CE Carabin H Carapetis J Carmona L Cella C Charlson F Chen H Cheng AT Chou D Chugh SS Coffeng LE Colan SD Colquhoun S Colson KE Condon J Connor MD Cooper LT Corriere M Cortinovis M de Vaccaro KC Couser W Cowie BC Criqui MH Cross M Dabhadkar KC Dahiya M Dahodwala N Damsere-Derry J Danaei G Davis A De Leo D Degenhardt L Dellavalle R Delossantos A Denenberg J Derrett S Des Jarlais DC Dharmaratne SD Dherani M Diaz-Torne C Dolk H Dorsey ER Driscoll T Duber H Ebel B Edmond K Elbaz A Ali SE Erskine H Erwin PJ Espindola P Ewoigbokhan SE Farzadfar F Feigin V Felson DT Ferrari A Ferri CP Fèvre EM Finucane MM Flaxman S Flood L Foreman K Forouzanfar MH Fowkes FG Fransen M Freeman MK Gabbe BJ Gabriel SE Gakidou E Ganatra HA Garcia B Gaspari F Gillum RF Gmel G Gonzalez-Medina D Gosselin R Grainger R Grant B Groeger J Guillemin F Gunnell D Gupta R Haagsma J Hagan H Halasa YA Hall W Haring D Haro JM Harrison JE Havmoeller R Hay RJ Higashi H Hill C Hoen B Hoffman H Hotez PJ Hoy D Huang JJ Ibeanusi SE Jacobsen KH James SL Jarvis D Jasrasaria R Jayaraman S Johns N Jonas JB Karthikeyan G Kassebaum N Kawakami N Keren A Khoo JP King CH Knowlton LM Kobusingye O Koranteng A Krishnamurthi R Laden F Lalloo R Laslett LL Lathlean T Leasher JL Lee YY Leigh J Levinson D Lim SS Limb E Lin JK Lipnick M Lipshultz SE Liu W Loane M Ohno SL Lyons R Mabweijano J MacIntyre MF Malekzadeh R Mallinger L Manivannan S Marcenes W March L Margolis DJ Marks GB Marks R Matsumori A Matzopoulos R Mayosi BM McAnulty JH McDermott MM McGill N McGrath J Medina-Mora ME Meltzer M Mensah GA Merriman TR Meyer AC Miglioli V Miller M Miller TR Mitchell PB Mock C Mocumbi AO Moffitt TE Mokdad AA Monasta L Montico M Moradi-Lakeh M Moran A Morawska L Mori R Murdoch ME Mwaniki MK Naidoo K Nair MN Naldi L Narayan KM Nelson PK Nelson RG Nevitt MC Newton CR Nolte S Norman P Norman R O'Donnell M O'Hanlon S Olives C Omer SB Ortblad K Osborne R Ozgediz D Page A Pahari B Pandian JD Rivero AP Patten SB Pearce N Padilla RP Perez-Ruiz F Perico N Pesudovs K Phillips D Phillips MR Pierce K Pion S Polanczyk GV Polinder S Pope CA III Popova S Porrini E Pourmalek F Prince M Pullan RL Ramaiah KD Ranganathan D Razavi H Regan M Rehm JT Rein DB Remuzzi G Richardson K Rivara FP Roberts T Robinson C De Leòn FR Ronfani L Room R Rosenfeld LC Rushton L Sacco RL Saha S Sampson U Sanchez-Riera L Sanman E Schwebel DC Scott JG Segui-Gomez M Shahraz S Shepard DS Shin H Shivakoti R Singh D Singh GM Singh JA Singleton J Sleet DA Sliwa K Smith E Smith JL Stapelberg NJ Steer A Steiner T Stolk WA Stovner LJ Sudfeld C Syed S Tamburlini G Tavakkoli M Taylor HR Taylor JA Taylor WJ Thomas B Thomson WM Thurston GD Tleyjeh IM Tonelli M Towbin JA Truelsen T Tsilimbaris MK Ubeda C Undurraga EA van der Werf MJ van Os J Vavilala MS Venketasubramanian N Wang M Wang W Watt K Weatherall DJ Weinstock MA Weintraub R Weisskopf MG Weissman MM White RA Whiteford H Wiebe N Wiersma ST Wilkinson JD Williams HC Williams SR Witt E Wolfe F Woolf AD Wulf S Yeh PH Zaidi AK Zheng ZJ Zonies D Lopez AD AlMazroa MA Memish ZA 2012 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet380:2197–2223
Not in our library10.1016/s0140-6736(12)61689-4
- 89.
Muyembe T Kipasa M 1995 Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and WHO Collaborating Centre for Haemorrhagic Fevers. Lancet345:1448
Not in our library10.1016/s0140-6736(95)92640-2
- 90.
NCBI 2014 GenBank - ebola. Accessed: August 2014. Available: http://www.ncbi.nlm.nih.gov/genbank/
Not in our library
- 91.
- 92.
NIH 2014 NIAID emerging infectious diseases/pathogens. Available: Accessed: August 2014
Not in our library
- 93.
Nkoghe D Formenty P Leroy EM Nnegue S Edou SY Ba JI Allarangar Y Cabore J Bachy C Andraghetti R de Benoist AC Galanis E Rose A Bausch D Reynolds M Rollin P Choueibou C Shongo R Gergonne B Koné LM Yada A Roth C Mve MT 2005 [Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002]. Bulletin de la Société de Pathologie Exotique98:224–229
Not in our library
- 94.
Nkoghe D Kone ML Yada A Leroy E 2011 A limited outbreak of Ebola haemorrhagic fever in Etoumbi, Republic of Congo, 2005. Transactions of the Royal Society of Tropical Medicine and Hygiene105:466–472
Not in our library10.1016/j.trstmh.2011.04.011
- 95.
Okware SI Omaswa FG Zaramba S Opio A Lutwama JJ Kamugisha J Rwaguma EB Kagwa P Lamunu M 2002 An outbreak of Ebola in Uganda. Tropical Medicine & International Health7:1068–1075
Not in our library10.1046/j.1365-3156.2002.00944.x
- 96.
- 97.
Onyango CO Opoka ML Ksiazek TG Formenty P Ahmed A Tukei PM Sang RC Ofula VO Konongoi SL Coldren RL Grein T Legros D Bell M De Cock KM Bellini WJ Towner JS Nichol ST Rollin PE 2007 Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. The Journal of Infectious Diseases196:S193–S198
Not in our library10.1086/520609
- 98.
ORNL DAAC 2000 Shuttle radar topography mission near-global digital elevation models. Accessed: August 2014. Available: http://webmap.ornl.gov/wcsdown/wcsdown.jsp?dg_id=10008_1
Not in our library
- 99.
Pattyn S Jacob W Vandergroen G Piot P Courteille G 1977 Isolation of Marburg-like virus from a case of hemorrhagic fever in Zaire. Lancet1:573–574
Not in our library10.1016/s0140-6736(77)92002-5
- 100.
- 101.
Peterson AT Carroll DS Mills JN Johnson KM 2004b Potential mammalian filovirus reservoirs. Emerging Infectious Diseases10:2073–2081
Not in our library10.3201/eid1012.040346
- 102.
Peterson AT Papes M Carroll DS Leirs H Johnson KM 2007 Mammal taxa constituting potential coevolved reservoirs of filoviruses. Journal of Mammalogy88:1544–1554
Not in our library10.1644/06-mamm-a-280r1.1
- 103.
Petter JJ Desbordes F 2013 Primates of the world. Princeton: Princeton University Press p. 186
Not in our library
- 104.
Phillips SJ Dudik M Elith J Graham CH Lehmann A Leathwick J Ferrier S 2009 Sample selection bias and presence-only distribution models: implications for background and pseudo-absence data. Ecological Applications19:181–197
Not in our library10.1890/07-2153.1
- 105.
- 106.
Pindolia DK Garcia AJ Huang ZJ Fik T Smith DL Tatem AJ 2014 Quantifying cross-border movements and migrations for guiding the strategic planning of malaria control and elimination. Malaria Journal13:169
Not in our library10.1186/1475-2875-13-169
- 107.
Pourrut X Delicat A Rollin PE Ksiazek TG Gonzalez JP Leroy EM 2007 Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. The Journal of Infectious Diseases196:S176–S183
Not in our library10.1086/520541
- 108.
Pourrut X Kumulungui B Wittmann T Moussavou G Délicat A Yaba P Nkoghe D Gonzalez JP Leroy EM 2005 The natural history of Ebola virus in Africa. Microbes and Infection7:1005–1014
Not in our library10.1016/j.micinf.2005.04.006
- 109.
- 110.
- 111.
Schipper J Chanson JS Chiozza F Cox NA Hoffmann M Katariya V Lamoreux J Rodrigues AS Stuart SN Temple HJ Baillie J Boitani L Lacher TE Jnr Mittermeier RA Smith AT Absolon D Aguiar JM Amori G Bakkour N Baldi R Berridge RJ Bielby J Black PA Blanc JJ Brooks TM Burton JA Butynski TM Catullo G Chapman R Cokeliss Z Collen B Conroy J Cooke JG da Fonseca GA Derocher AE Dublin HT Duckworth JW Emmons L Emslie RH Festa-Bianchet M Foster M Foster S Garshelis DL Gates C Gimenez-Dixon M Gonzalez S Gonzalez-Maya JF Good TC Hammerson G Hammond PS Happold D Happold M Hare J Harris RB Hawkins CE Haywood M Heaney LR Hedges S Helgen KM Hilton-Taylor C Hussain SA Ishii N Jefferson TA Jenkins RK Johnston CH Keith M Kingdon J Knox DH Kovacs KM Langhammer P Leus K Lewison R Lichtenstein G Lowry LF Macavoy Z Mace GM Mallon DP Masi M McKnight MW Medellín RA Medici P Mills G Moehlman PD Molur S Mora A Nowell K Oates JF Olech W Oliver WR Oprea M Patterson BD Perrin WF Polidoro BA Pollock C Powel A Protas Y Racey P Ragle J Ramani P Rathbun G Reeves RR Reilly SB Reynolds JE III Rondinini C Rosell-Ambal RG Rulli M Rylands AB Savini S Schank CJ Sechrest W Self-Sullivan C Shoemaker A Sillero-Zubiri C De Silva N Smith DE Srinivasulu C Stephenson PJ van Strien N Talukdar BK Taylor BL Timmins R Tirira DG Tognelli MF Tsytsulina K Veiga LM Vié JC Williamson EA Wyatt SA Xie Y Young BE 2008 The status of the world's land and marine mammals: diversity, threat, and knowledge. Science322:225–230
Not in our library10.1126/science.1165115
- 112.
Seto KC Guneralp B Hutyra LR 2012 Global forecasts of urban expansion to 2030 and direct impacts on biodiversity and carbon pools. Proceedings of the National Academy of Sciences of USA109:16083–16088
Not in our library10.1073/pnas.1211658109
- 113.
Shoemaker T MacNeil A Balinandi S Campbell S Wamala JF McMullan LK Downing R Lutwama J Mbidde E Ströher U Rollin PE Nichol ST 2012 Reemerging Sudan ebola virus disease in Uganda, 2011. Emerging Infectious Diseases18:1480–1483
Not in our library10.3201/eid1809.111536
- 114.
Siegert R Shu H-L Slenczka W Peters D Mueller G 1967 Zur Ätiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit. Deutsche Medizinische Wochenschrift92:2341–2343
Not in our library10.1055/s-0028-1106144
- 115.
Simini F Gonzalez MC Maritan A Barabasi AL 2012 A universal model for mobility and migration patterns. Nature484:96–100
Not in our library10.1038/nature10856
- 116.
Simini F Maritan A Neda Z 2013 Human mobility in a continuum approach. PLOS ONE8:e60069
Not in our library10.1371/journal.pone.0060069
- 117.
- 118.
Smith DH Isaacson M Johnson KM Bagshawe A Johnson BK Swanapoel R Killey M Siongok T Keruga WK 1982 Marburg virus disease in Kenya. Lancet1:816–820
Not in our library10.1016/s0140-6736(82)91871-2
- 119.
Stockwell D Peters D 1999 The GARP modelling system: problems and solutions to automated spatial prediction. International Journal of Geographical Information Science13:143–158
Not in our library10.1080/136588199241391
- 120.
- 121.
- 122.
Tatem AJ Goetz SJ Hay SI 2004 Terra and aqua: new data for epidemiology and public health. International Journal of Applied Earth Observation and Geoinformation6:33–46
Not in our library10.1016/j.jag.2004.07.001
- 123.
Tignor GH Casals J Shope RE 1993 The Yellow Fever epidemic in Ethiopia, 1961-1962-retrospective serological evidence for concomitant Ebola or Ebola-like virus infection. Transactions of the Royal Society of Tropical Medicine and Hygiene87:162–162
Not in our library10.1016/0035-9203(93)90471-2
- 124.
- 125.
Towner JS Khristova ML Sealy TK Vincent MJ Erickson BR Bawiec DA Hartman AL Comer JA Zaki SR Ströher U Gomes da Silva F del Castillo F Rollin PE Ksiazek TG Nichol ST 2006 Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. Journal of Virology80: 6497–6516
Not in our library10.1128/jvi.00069-06
- 126.
- 127.
Trabucco A Zomer RJ 2009 Global Aridity Index (Global-Aridity) and global potential Evapo-Transpiration (Global-PET) Geospatial database. Accessed: August 2014. Available: http://www.csi.cgiar.org
Not in our library
- 128.
Walsh PD Bermejo M Rodriguez-Teijeiro JD 2009 Disease avoidance and the evolution of primate social connectivity: Ebola, bats, gorillas, and chimpanzees. In: Huffman MA Chapman CA, editors. Primate parasite ecology: the dynamics and study of host-parasite relationships. Cambridge: Cambridge University Press p. 183–197
Not in our library
- 129.
- 130.
Wan ZM Li ZL 1997 A physics-based algorithm for retrieving land-surface emissivity and temperature from EOS/MODIS data. IEEE Transactions on Geoscience and Remote Sensing35:980–996
Not in our library10.1109/36.602541
- 131.
Wang H Liddell CA Coates MM Mooney MD Levitz CE Schumacher AE Apfel H Iannarone M Phillips B Lofgren KT Sandar L Dorrington RE Rakovac I Jacobs TA Liang X Zhou M Zhu J Yang G Wang Y Liu S Li Y Ozgoren AA Abera SF Abubakar I Achoki T Adelekan A Ademi Z Alemu ZA Allen PJ Almazroa MA Alvarez E Amankwaa AA Amare AT Ammar W Anwari P Cunningham SA Asad MM Assadi R Banerjee A Basu S Bedi N Bekele T Bell ML Bhutta Z Blore J Basara BB Boufous S Breitborde N Bruce NG Bui LN Carapetis JR Cárdenas R Carpenter DO Caso V Castro RE Catalá-Lopéz F Cavlin A Che X Chiang PP Chowdhury R Christophi CA Chuang TW Cirillo M da Costa Leite I Courville KJ Dandona L Dandona R Davis A Dayama A Deribe K Dharmaratne SD Dherani MK Dilmen U Ding EL Edmond KM Ermakov SP Farzadfar F Fereshtehnejad SM Fijabi DO Foigt N Forouzanfar MH Garcia AC Geleijnse JM Gessner BD Goginashvili K Gona P Goto A Gouda HN Green MA Greenwell KF Gugnani HC Gupta R Hamadeh RR Hammami M Harb HL Hay S Hedayati MT Hosgood HD Hoy DG Idrisov BT Islami F Ismayilova S Jha V Jiang G Jonas JB Juel K Kabagambe EK Kazi DS Kengne AP Kereselidze M Khader YS Khalifa SE Khang YH Kim D Kinfu Y Kinge JM Kokubo Y Kosen S Defo BK Kumar GA Kumar K Kumar RB Lai T Lan Q Larsson A Lee JT Leinsalu M Lim SS Lipshultz SE Logroscino G Lotufo PA Lunevicius R Lyons RA Ma S Mahdi AA Marzan MB Mashal MT Mazorodze TT McGrath JJ Memish ZA Mendoza W Mensah GA Meretoja A Miller TR Mills EJ Mohammad KA Mokdad AH Monasta L Montico M Moore AR Moschandreas J Msemburi WT Mueller UO Muszynska MM Naghavi M Naidoo KS Narayan KV Nejjari C Ng M de Dieu Ngirabega J Nieuwenhuijsen MJ Nyakarahuka L Ohkubo T Omer SB Caicedo AJ Wyk VP Pope D Prabhakaran D Rahman SU Rana SM Reilly RQ Rojas-Rueda D Ronfani L Rushton L Saeedi MY Salomon J Sampson U Santos IS Sawhney M Schmidt JC Shakh-Nazarova M She J Sheikhbahaei S Shibuya K Shin HH Shishani K Shiue I Sigfusdottir ID Singh JA Skirbekk V Sliwa K Soshnikov SS Sposato LA Stathopoulou VK Stroumpoulis K Tabb KM Talongwa RT Teixeira CM Terkawi AS Thomson AJ Thorne-Lyman AL Toyoshima H Dimbuene ZT Uwaliraye P Uzun SB Vasankari TJ Vasconcelos AM Vlassov VV Vollset SE Vos T Waller S Wan X Weichenthal S Weiderpass E Weintraub RG Westerman R Wilkinson JD Williams HC Yang YC Yentur GK Yip P Yonemoto N Younis M Yu C Jin KY El Sayed Zaki M Zhu S Lopez AD Murray CJ 2014 Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet:
Not in our library10.1016/s0140-6736(14)60497-9
- 132.
Weiss DJ Atkinson PM Bhatt S Mappin B Hay SI Gething PW 2014a An effective approach for gap-filling continental scale remotely sensed time-series. ISPRS Journal of Photogrammetry and Remote Sensingaccepted manuscript
Not in our library10.1016/j.isprsjprs.2014.10.001
- 133.
Weiss DJ Bhatt S Mappin B Van Boeckel TP Smith DL Hay SI Gething PW 2014b Air temperature suitability for Plasmodium falciparum malaria transmission in Africa 2000-2012: a high-resolution spatiotemporal prediction. Malaria Journal13:171
Not in our library10.1186/1475-2875-13-171
- 134.
Wenger SJ Olden JD 2012 Assessing transferability of ecological models: an underappreciated aspect of statistical validation. Methods in Ecology and Evolution3:260–267
Not in our library10.1111/j.2041-210x.2011.00170.x
- 135.
Wesolowski A Buckee CO Pindolia DK Eagle N Smith DL Garcia AJ Tatem AJ 2013 The use of census migration data to approximate human movement patterns across temporal scales. PLOS ONE8:e52971
Not in our library10.1371/journal.pone.0052971
- 136.
Wesolowski A Eagle N Tatem AJ Smith DL Noor AM Snow RW Buckee CO 2012 Quantifying the impact of human mobility on malaria. Science338:267–270
Not in our library10.1126/science.1223467
- 137.
WHO 2001 Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001. Weekly Epidemiological Record76:41–46
Not in our library
- 138.
WHO 2003a Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Weekly Epidemiological Record78:223–228
Not in our library
- 139.
WHO 2003b Outbreak(s) of Ebola haemorrhagic fever in the Republic of the Congo, January-April 2003. Weekly Epidemiological Record78:285–289
Not in our library
- 140.
WHO 2005 Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April - June 2004. Weekly Epidemiological Record80:370–375
Not in our library
- 141.
WHO 2012a Ebola in Uganda - 29 July 2012. Accessed: August 2014. Available: http://www.who.int/csr/don/2012_07_29/en/
Not in our library
- 142.
WHO 2012b Ebola outbreak in democratic Republic of Congo - 17 August 2012. Accessed: August 2014. Available: http://www.who.int/csr/don/2012_08_18/en/
Not in our library
- 143.
WHO 2012c Ebola in Uganda - 17 November 2012. Accessed: August 2014. Available: http://www.who.int/csr/don/2012_11_17/en/
Not in our library
- 144.
WHO 2014a Ebola virus disease update - west Africa. Accessed: August 2014. Available: http://www.who.int/csr/don/2014_08_15_ebola/en/
Not in our library
- 145.
WHO 2014b Health statistics and information systems - definition of region groupings. Accessed: August 2014. Available: http://www.who.int/healthinfo/global_burden_disease/definition_regions/en/
Not in our library
- 146.
WHO 2014c Interim manual - Ebola and Marburg virus disease epidemics: preparedness, alert, control, and evaluation. Geneva: World Health Organization P. 123
Not in our library
- 147.
WHO 2014d WHO statement on the meeting of the International Health Regulations Emergency Committee regarding the 2014 Ebola outbreak in West Africa. Accessed: August 2014. Available: http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/
Not in our library
- 148.
WHO International Study Team 1978 Ebola haemorrhagic fever in Sudan, 1976. Bulletin of the World Health Organization56:247–270
Not in our library
- 149.
Wittmann TJ Biek R Hassanin A Rouquet P Reed P Yaba P Pourrut X Real LA Gonzalez JP Leroy EM 2007 Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. Proceedings of the National Academy of Sciences of USA104:17123–17127
Not in our library10.1073/pnas.0704076104
- 150.
- 151.
Wolfe ND Dunavan CP Diamond J 2007 Origins of major human infectious diseases. Nature447:279–283
Not in our library10.1038/nature05775
- 152.
World Bank 2014 World Bank open dataset. Accessed: July 2014. Available: http://data.worldbank.org/
Not in our library
- 153.
WorldPop 2014 WorldPop project. Accessed: August 2014. Available: http://www.worldpop.org.uk/
Not in our library
- 154.
WWF 2014 List of terrestrial ecoregions. Accessed: August 2014. Available: http://wwf.panda.org/about_our_earth/ecoregions/ecoregion_list/
Not in our library
- 155.
Yang Y Atkinson P Ettema D 2008 Individual space-time activity-based modelling of infectious disease transmission within a city. Journal of the Royal Society, Interface5:759–772
Not in our library10.1098/rsif.2007.1218
- 156.
Zipf GK 1946 The P1 P2/D hypothesis: on the intercity movement of persons. American Sociological Review11:677–686
Not in our library10.2307/2087063
Cited by papers we hold 11
- Version 3 of the Global Aridity Index and Potential Evapotranspiration Database · 2022No notice
- Zoonotic spillover: Understanding basic aspects for better prevention · 2021No notice
- Geospatial Science and Point-of-Care Testing: Creating Solutions for Population Access, Emergencies, Outbreaks, and Disasters · 2019Not checked
- Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease · 2017Not checked
- The nexus between forest fragmentation in Africa and Ebola virus disease outbreaks · 2017No notice
- Testing New Hypotheses Regarding Ebolavirus Reservoirs · 2016Not checked
- The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus · 2015No notice
- What Factors Might Have Led to the Emergence of Ebola in West Africa? · 2015No notice
- Mapping the zoonotic niche of Lassa fever in Africa · 2015No notice
- New Routes to Phylogeography: A Bayesian Structured Coalescent Approximation · 2015No notice
- The global distribution of Crimean-Congo hemorrhagic fever · 2015No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.